Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men

March 13, 2014 updated by: National Taiwan University Hospital
To determine the long-term survival outcome of subjects who had various PSA levels at screening

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

27741

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taipei city, Taiwan, 100
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

41 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Taiwanese healthy men who are older than 40 years

Description

Inclusion Criteria:

  • Health men who received PSA screening at NTUH and CGMH

Exclusion Criteria:

  • Prior history of prostate cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Healthy men
Healthy men who received PSA screening

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Diagnosis of prostate cancer
Time Frame: 20 years (average)
20 years (average)

Secondary Outcome Measures

Outcome Measure
Time Frame
Cancer-specific death
Time Frame: 20 years (average)
20 years (average)
Overall survival
Time Frame: 20 years (average)
20 years (average)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Taiwan University Hospital

Investigators

  • Principal Investigator: Yeong-Shiau Pu, PhD, National Taiwan University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

April 1, 2012

Study Registration Dates

First Submitted

May 16, 2012

First Submitted That Met QC Criteria

March 13, 2014

First Posted (Estimate)

March 14, 2014

Study Record Updates

Last Update Posted (Estimate)

March 14, 2014

Last Update Submitted That Met QC Criteria

March 13, 2014

Last Verified

March 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 200809020

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prostate Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe